UB Paderborn / Katalog / Suche / in CDI

NRF2 in dermo‐cosmetic: From scientific knowledge to skin care products

BioFactors (Oxford), 2023-01, Vol.49 (1), p.32-61

2023

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria as a target in treatment

Environmental and molecular mutagenesis, 2010-06, Vol.51 (5), p.462-475

2010

Link zum Volltext

Verfügbarkeit prüfen

Screening Ionic Solvents for Enhancing the Solubility of Water-Insoluble Natural Dyes

Industrial & engineering chemistry research, 2021-06, Vol.60 (23), p.8555-8564

2021

Link zum Volltext

Verfügbarkeit prüfen

Divergent Entry to C‑Glycosides from Unprotected Sugars

Organic letters, 2019-04, Vol.21 (8), p.2684-2687

2019

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking the DFT methodology for assessing antioxidant-related properties: quercetin and edaravone as case studies

Journal of molecular modeling, 2016-10, Vol.22 (10), p.250-10, Article 250

2016

Link zum Volltext

Verfügbarkeit prüfen

Large-Scale Asymmetric Synthesis of the Bioprotective Agent JP4-039 and Analogs

Organic letters, 2011-05, Vol.13 (9), p.2318-2321

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria

Organic & biomolecular chemistry, 2013-07, Vol.11 (25), p.4147-4153

2013

Link zum Volltext

Verfügbarkeit prüfen

Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist

Journal of medicinal chemistry, 2010-02, Vol.53 (4), p.1546-1562

2010

Link zum Volltext

Verfügbarkeit prüfen

UN sustainable development goals: How can sustainable/green chemistry contribute? Green chemistry as a source of sustainable innovations in the cosmetic industry

Current opinion in green and sustainable chemistry, 2018-10, Vol.13, p.164-169

2018

Link zum Volltext

Verfügbarkeit prüfen

Solid-Phase Organic Tagging Resins for Labeling Biomolecules by 1,3-Dipolar Cycloaddition: Application to the Synthesis of a Fluorescent Non-Peptidic Vasopressin Receptor Ligand

Chemistry : a European journal, 2008-07, Vol.14 (20), p.6247-6254

2008

Link zum Volltext

Verfügbarkeit prüfen

Fragment pharmacophore-based in silico screening: a powerful approach for efficient lead discovery

MedChemComm, 2016-03, Vol.7 (3), p.506-511

2016

Link zum Volltext

Verfügbarkeit prüfen

L'Oreal's comment on P. Anastas article “The UN Sustainability Goals: How can Sustainable Chemistry Contribute”

Current opinion in green and sustainable chemistry, 2018-10, Vol.13, p.171-171

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Structure−Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D

ACS medicinal chemistry letters, 2011-02, Vol.2 (2), p.154-159

2011

Link zum Volltext

Verfügbarkeit prüfen

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism

Journal of medicinal chemistry, 2018-10, Vol.61 (19), p.8670-8692

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction to Divergent Entry to C‑Glycosides from Unprotected Sugars

Organic letters, 2019-05, Vol.21 (9), p.3470-3470

2019

Link zum Volltext

Verfügbarkeit prüfen

Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus

Journal of the American Society of Nephrology, 2009-10, Vol.20 (10), p.2190-2203

2009

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

Pharmaceutics, 2011-04, Vol.3 (2), p.186-228

2011

Link zum Volltext

Verfügbarkeit prüfen

GS-Nitroxide (JP4-039)-Mediated Radioprotection of Human Fanconi Anemia Cell Lines

Radiation research, 2011-11, Vol.176 (5), p.603-612

2011

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria as a Target in Treatment: The Mitochondrial Genome: Dynamics, Mechanisms of Repair, and a Target in Disease and Therapy

Environmental and molecular mutagenesis, 2010, Vol.51 (5), p.462-475

2010

Link zum Volltext

Verfügbarkeit prüfen

Fragment pharmacophore-based in silico screening: a powerful approach for efficient lead discoveryThe authors declare no competing interests

2016-03

Link zum Volltext

Verfügbarkeit prüfen

Two Strategies for the Development of Mitochondrial-Targeted Small Molecule Radiation Damage Mitigators

International journal of radiation oncology, biology, physics, 2011-04, Vol.80 (3), p.860-868

2011

Link zum Volltext

Verfügbarkeit prüfen

Fragment pharmacophore-based in silicoscreening: a powerful approach for efficient lead discovery

MedChemComm, 2016-03, Vol.7 (3), p.506-511

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

NRF2 in dermo‐cosmetic: From scientific knowledge to skin care products

Mitochondria as a target in treatment

Screening Ionic Solvents for Enhancing the Solubility of Water-Insoluble Natural Dyes

Divergent Entry to C‑Glycosides from Unprotected Sugars

Benchmarking the DFT methodology for assessing antioxidant-related properties: quercetin and edaravone as case studies

Large-Scale Asymmetric Synthesis of the Bioprotective Agent JP4-039 and Analogs

Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria

Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist

UN sustainable development goals: How can sustainable/green chemistry contribute? Green chemistry as a source of sustainable innovations in the cosmetic industry

Solid-Phase Organic Tagging Resins for Labeling Biomolecules by 1,3-Dipolar Cycloaddition: Application to the Synthesis of a Fluorescent Non-Peptidic Vasopressin Receptor Ligand

Fragment pharmacophore-based in silico screening: a powerful approach for efficient lead discovery

L'Oreal's comment on P. Anastas article “The UN Sustainability Goals: How can Sustainable Chemistry Contribute”

Synthesis and Structure−Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D

Back Cover: Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action (ChemMedChem 18/2016)

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism

Correction to Divergent Entry to C‑Glycosides from Unprotected Sugars

Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus

Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

GS-Nitroxide (JP4-039)-Mediated Radioprotection of Human Fanconi Anemia Cell Lines

Mitochondria as a Target in Treatment: The Mitochondrial Genome: Dynamics, Mechanisms of Repair, and a Target in Disease and Therapy

Fragment pharmacophore-based in silico screening: a powerful approach for efficient lead discoveryThe authors declare no competing interests

Two Strategies for the Development of Mitochondrial-Targeted Small Molecule Radiation Damage Mitigators

Fragment pharmacophore-based in silicoscreening: a powerful approach for efficient lead discovery

Suchergebnisse filtern